Cargando…
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
While tumor genome sequencing has become widely available in clinical and research settings, the interpretation of tumor somatic variants remains an important bottleneck. Here we present the Cancer Genome Interpreter, a versatile platform that automates the interpretation of newly sequenced cancer g...
Autores principales: | Tamborero, David, Rubio-Perez, Carlota, Deu-Pons, Jordi, Schroeder, Michael P., Vivancos, Ana, Rovira, Ana, Tusquets, Ignasi, Albanell, Joan, Rodon, Jordi, Tabernero, Josep, de Torres, Carmen, Dienstmann, Rodrigo, Gonzalez-Perez, Abel, Lopez-Bigas, Nuria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875005/ https://www.ncbi.nlm.nih.gov/pubmed/29592813 http://dx.doi.org/10.1186/s13073-018-0531-8 |
Ejemplares similares
-
Rational design of cancer gene panels with OncoPaD
por: Rubio-Perez, Carlota, et al.
Publicado: (2016) -
IntOGen-mutations identifies cancer drivers across tumor types
por: Gonzalez-Perez, Abel, et al.
Publicado: (2013) -
Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation
por: Gonzalez-Perez, Abel, et al.
Publicado: (2012) -
OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action
por: Schroeder, Michael P., et al.
Publicado: (2014) -
OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations
por: Mularoni, Loris, et al.
Publicado: (2016)